Comparison of α/β estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

Medical Physics

Volumn 30, Issue 10, 2003, Pages 2832-2848

  Carlone, Marco ^a   Wilkins, David ^b   Nyiri, Balazs ^b   Raaphorst, Peter ^b  

^a CARLETON UNIVERSITY   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Alpha beta ratio; Heterogeneity; Monte Carlo; Prostate cancer; Tumor control modeling

Indexed keywords

DISEASES; ERROR STATISTICS; MONTE CARLO METHODS; POPULATION STATISTICS; STEM CELLS; TUMORS; UROLOGY;

ALPHA/BETA RATIO; HETEROGENEITY; HETEROGENEOUS MODELING; LINEAR-QUADRATIC MODELS; PROSTATE CANCERS; RADIOBIOLOGICAL PARAMETERS; STATISTICAL SIGNIFICANCE; TUMOR CONTROL;

PARAMETER ESTIMATION;

ARTICLE; CANCER CONTROL; CELL SURVIVAL; MATHEMATICAL MODEL; MONTE CARLO METHOD; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOBIOLOGY; RADIOSENSITIVITY;

EID: 0142089313     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1612946     Document Type: Article

References (25)

1. J. D. Fenwick, "Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression," Phys. Med. Biol. 43, 2159-2178 (1998).
2. S. Levegrun, A. Jackson, M. J. Zelefsky, M. W. Skwarchuk, E. S. Venkatraman, W. Schlegel, Z. Fuks, S. A. Leibel, and C. C. Ling, "Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data," Int. J. Radiat. Oncol., Biol., Phys. 51, 1064-1080 (2001).
3. S. Webb, "Optimum parameters in a model for tumor control probability including interpatient heterogeneity," Phys. Med. Biol. 39, 1895-1914 (1994).
4. A. Niemierko and M. Goitein, "Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor," Radiother. Oncol. 29, 140-147 (1993).
5. S. Webb and A. E. Nahum, "A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density," Phys. Med. Biol. 38, 653-666 (1993).
6. R. G. Stock, N. N. Stone, A. Tabert, C. Iannuzzi, and J. K. DeWyngaert, "A dose-response study for 1-125 prostate implants," Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
7. G. E. Hanks, T. E. Schultheiss, A. L. Hanlon, M. Hunt, W. R. Lee, B. E. Epstein, and L. R. Coia, "Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study," Int. J. Radiat. Oncol., Biol., Phys. 37, 543-550 (1997).
8. W. H. Pinover, A. L. Hanlon, E. M. Horwitz, and G. E. Hanks, "Defining the appropriate radiation dose for pretreatment PSA
9. "Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel," Int. J. Radiat. Oncol., Biol., Phys. 37, 1035-1041 (1997).
10. S. A. Roberts and J. H. Hendry, "A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity," Int. J. Radiat. Oncol., Biol., Phys. 41, 689-699 (1998).
11. P. Stravev, B. Warkentin, N. Stavreva, and G. Fallone, "Evaluation of a closed-form tumor-control probability solution," Med. Phys. 29, 1294-1294 (2002).
12. R. G. Dale and B. Jones, "Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031," Int. J. Radiat. Oncol., Biol., Phys. 52, 1427-1428 (2002).
13. 103Pd brachytherapy sources using the concept of proximity function," Med. Phys. 25, 2186-2189 (1998).
14. 125I brachytherapy seed with characteristic x rays from its constitutive materials," Med. Phys. 29, 1397-1402 (2002).
15. G. Cowan, Statistical Data Analysis (Clarendon, Oxford, 1998).
16. W. H. Press, B. P. Flannery, S. A. Teukolsky, and W. T. Vetterling, Numerical Recipes in C (Cambridge University Press, Cambridge, MA, 1988).
17. B. M. Dubray and H. D. Thames, "The clinical significance of ratios of radiobiological parameters," Int. J. Radiat. Oncol., Biol., Phys. 35, 1099-1111 (1996).
18. D. J. Brenner, "Toward optimal external-beam fractionation for prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 48, 315-316 (2000).
19. J. Fowler, R. Chappell, and M. Ritter, "Is alpha/beta for prostate tumors really low?" Int. J. Radiat. Oncol., Biol., Phys. 50, 1021-1031 (2001).
20. C. R. King and J. F. Fowler, "A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low," Int. J. Radiat. Oncol., Biol., Phys. 51, 213-214 (2001).
21. D. J. Brenner and E. J. Hall, "Fractionation and protraction for radiotherapy of prostate carcinoma," Int. J. Radiat. Oncol., Biol., Phys. 43, 1095-1101 (1999).
22. D. J. Brenner, A. A. Martinez, G. K. Edmundson, C. Mitchell, H. D. Thames, and E. P. Armour, "Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue," Int. J. Radiat. Oncol., Biol., Phys. 52, 6-13 (2002).
23. J. Z. Wang, M. Guerrero, and X. A. Li, "How low is the alpha/beta ratio for prostate cancer?" Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003).
24. F. M. Buffa, S. E. Davidson, R. D. Hunter, A. E. Nahum, and C. M. West, "Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 50, 1113-1122 (2001).
25. M. Zaider and G. N. Minerbo, "Tumour control probability: a formulation applicable to any temporal protocol of dose delivery," Phys. Med. Biol. 45, 279-293 (2000).